254 related articles for article (PubMed ID: 31207943)
21. NHERF1 inhibits proliferation of triple-negative breast cancer cells by suppressing GPER signaling.
Wang Y; Peng Z; Meng R; Tao T; Wang Q; Zhao C; Liu H; Song R; Zheng J; Qin Q; He J
Oncol Rep; 2017 Jul; 38(1):221-228. PubMed ID: 28535016
[TBL] [Abstract][Full Text] [Related]
22. Insight into the mechanism of tetrachlorobisphenol A (TCBPA)-induced proliferation of breast cancer cells by GPER-mediated signaling pathways.
Lei B; Tang Q; Sun S; Zhang X; Huang Y; Xu L
Environ Pollut; 2021 Apr; 275():116636. PubMed ID: 33582643
[TBL] [Abstract][Full Text] [Related]
23. The sequence Pro295-Thr311 of the hinge region of oestrogen receptor α is involved in ERK1/2 activation via GPR30 in leiomyoma cells.
Leiber D; Burlina F; Byrne C; Robin P; Piesse C; Gonzalez L; Leclercq G; Tanfin Z; Jacquot Y
Biochem J; 2015 Nov; 472(1):97-109. PubMed ID: 26371374
[TBL] [Abstract][Full Text] [Related]
24. Identification of Breast Cancer Inhibitors Specific for G Protein-Coupled Estrogen Receptor (GPER)-Expressing Cells.
Aiello F; Carullo G; Giordano F; Spina E; Nigro A; Garofalo A; Tassini S; Costantino G; Vincetti P; Bruno A; Radi M
ChemMedChem; 2017 Aug; 12(16):1279-1285. PubMed ID: 28520140
[TBL] [Abstract][Full Text] [Related]
25. Improvement of the anti-proliferative activity of the peptide ERα17p in MCF-7 breast cancer cells using nanodiamonds.
Yip F; Nemati F; El Botty R; Belnou M; Decaudin D; Mansuy C; Jacquot Y
Ann Pharm Fr; 2019 Nov; 77(6):488-495. PubMed ID: 31563266
[TBL] [Abstract][Full Text] [Related]
26. ER-mediated anti-tumor effects of shikonin on breast cancer.
Yang Y; Gao W; Tao S; Wang Y; Niu J; Zhao P; Rao C; Yang L
Eur J Pharmacol; 2019 Nov; 863():172667. PubMed ID: 31545985
[TBL] [Abstract][Full Text] [Related]
27. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
[TBL] [Abstract][Full Text] [Related]
28. G-Protein Coupled Estrogen Receptor in Breast Cancer.
Hsu LH; Chu NM; Lin YF; Kao SH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646517
[TBL] [Abstract][Full Text] [Related]
29. GPER Mediates Non-Genomic Effects of Estrogen.
Pupo M; Maggiolini M; Musti AM
Methods Mol Biol; 2016; 1366():471-488. PubMed ID: 26585158
[TBL] [Abstract][Full Text] [Related]
30. The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro.
Han N; Heublein S; Jeschke U; Kuhn C; Hester A; Czogalla B; Mahner S; Rottmann M; Mayr D; Schmoeckel E; Trillsch F
Cells; 2021 Mar; 10(3):. PubMed ID: 33799631
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells.
Shi D; Zhao P; Cui L; Li H; Sun L; Niu J; Chen M
BMC Pharmacol Toxicol; 2020 May; 21(1):32. PubMed ID: 32357920
[TBL] [Abstract][Full Text] [Related]
32. GPER functions as a tumor suppressor in triple-negative breast cancer cells.
Weißenborn C; Ignatov T; Ochel HJ; Costa SD; Zenclussen AC; Ignatova Z; Ignatov A
J Cancer Res Clin Oncol; 2014 May; 140(5):713-23. PubMed ID: 24553912
[TBL] [Abstract][Full Text] [Related]
33. Estetrol/GPER/SERPINB2 transduction signaling inhibits the motility of triple-negative breast cancer cells.
Cirillo F; Spinelli A; Talia M; Scordamaglia D; Santolla MF; Grande F; Rizzuti B; Maggiolini M; Gérard C; Lappano R
J Transl Med; 2024 May; 22(1):450. PubMed ID: 38741146
[TBL] [Abstract][Full Text] [Related]
34. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
35. Estrogenic gper signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (cafs).
Vivacqua A; De Marco P; Santolla MF; Cirillo F; Pellegrino M; Panno ML; Abonante S; Maggiolini M
Oncotarget; 2015 Jun; 6(18):16573-87. PubMed ID: 26030000
[TBL] [Abstract][Full Text] [Related]
36. The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells.
Ribeiro MPC; Santos AE; Custódio JBA
Chem Biol Interact; 2017 Nov; 277():176-184. PubMed ID: 28947257
[TBL] [Abstract][Full Text] [Related]
37. Bisphenol A induces focal adhesions assembly and activation of FAK, Src and ERK2 via GPER in MDA-MB-231 breast cancer cells.
Castillo-Sanchez R; Ramirez-Ricardo J; Martinez-Baeza E; Cortes-Reynosa P; Candanedo-Gonzales F; Gomez R; Salazar EP
Toxicol In Vitro; 2020 Aug; 66():104871. PubMed ID: 32325111
[TBL] [Abstract][Full Text] [Related]
38. GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells.
Rigiracciolo DC; Scarpelli A; Lappano R; Pisano A; Santolla MF; Avino S; De Marco P; Bussolati B; Maggiolini M; De Francesco EM
Oncotarget; 2016 Jan; 7(1):94-111. PubMed ID: 26646587
[TBL] [Abstract][Full Text] [Related]
39. Role of GPER on proliferation, migration and invasion in ligand-independent manner in human ovarian cancer cell line SKOV3.
Yan Y; Jiang X; Zhao Y; Wen H; Liu G
Cell Biochem Funct; 2015 Dec; 33(8):552-9. PubMed ID: 26526233
[TBL] [Abstract][Full Text] [Related]
40. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]